BMSSC
IDYA icon

B. Metzler seel. Sohn & Co’s IDEAYA Biosciences IDYA Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,276
Closed -$943K – 733
2025
Q4 		$943K Hold
27,276
– – 0.01% 553
2025
Q3 		$742K Hold
27,276
– – 0.01% 597
2025
Q2 		$573K Hold
27,276
– – 0.01% 627
2025
Q1 		$447K Hold
27,276
– – ﹤0.01% 637
2024
Q4 		$701K Buy
+27,276
New +$772K 0.01% 603

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

B. Metzler seel. Sohn & Co's IDYA Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 27,276 shares — an estimated $943K sold.

B. Metzler seel. Sohn & Co first reported a position in IDYA in Q4 2024 and held it in 5 quarters. The position peaked at $943K in Q4 2025. 254 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • B. Metzler seel. Sohn & Co reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 27,276 IDEAYA Biosciences shares in Q1 2026, an estimated $943K.
  • B. Metzler seel. Sohn & Co first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 5 quarters.
  • B. Metzler seel. Sohn & Co's IDEAYA Biosciences position peaked at $943K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.